-
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced.
-
In Oregon, some are seeking out psilocybin for relief from mental health issues. But tracking the effects of that treatment is very much a work in progress.
-
Australian physicians can prescribe doses of MDMA, aka ecstasy, for PTSD. Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people with hard-to-treat depression.
-
Thousands are in Denver this week to learn about the future of psychedelics like magic mushrooms and MDMA, and to talk business.
-
The market for gummies, powders and capsules containing extracts of the fungus is raising eyebrows, though, amid concerns from the FDA and in the absence of human clinical trials.
-
A group of former pro athletes traveled to Jamaica to try psychedelics as a way to help cope with the aftereffects of concussions and a career of body-pounding injuries. Will this still largely untested treatment work?
-
Research into psychedelic drugs was halted in the 1960s amid concern about recreational use. Now, the VA is among dozens of medical providers resuming that work.
-
As efforts grow to decriminalize psilocybin, advocates in Washington state are pushing to make magic mushrooms available to dying patients even sooner using Right to Try laws.
-
Denver could be the first place to decriminalize psychedelic mushrooms if voters pass a ballot measure today. Supporters point to research finding therapeutic effects from fungi containing psilocybin.